IL6 and cancer: In prostate cancer models, sevoflurane increased cancer cell invasion and lung metastasis by increasing macrophage M2 polarization through the Il-6/HO-1 pathway, again demonstrating its potential to facilitate cancer metastasis and worsen clinical outcomes [20].